Cargando…
Recent Innovations and Nano-Delivery of Actinium-225: A Narrative Review
The actinium-225 ((225)Ac) radioisotope exhibits highly attractive nuclear properties for application in radionuclide therapy. However, the (225)Ac radionuclide presents multiple daughter nuclides in its decay chain, which can escape the targeted site, circulate in plasma, and cause toxicity in area...
Autores principales: | Mdanda, Sipho, Ngema, Lindokuhle M., Mdlophane, Amanda, Sathekge, Mike M., Zeevaart, Jan Rijn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304099/ https://www.ncbi.nlm.nih.gov/pubmed/37376167 http://dx.doi.org/10.3390/pharmaceutics15061719 |
Ejemplares similares
-
An Overview of Targeted Alpha Therapy with (225)Actinium and (213)Bismuth
por: Morgenstern, Alfred, et al.
Publicado: (2018) -
Synthesis and Stability of Actinium-225 Endohedral
Fullerenes, (225)Ac@C(60)
por: Mwakisege, Jofa Gideon, et al.
Publicado: (2020) -
Supply and Clinical Application of Actinium-225 and Bismuth-213
por: Morgenstern, Alfred, et al.
Publicado: (2020) -
The determination of the radiochemical purity of Actinium-225 radiopharmaceuticals: a conundrum
por: Kleynhans, Janke, et al.
Publicado: (2022) -
In vitro dose effect relationships of actinium-225- and lutetium-177-labeled PSMA-I&T
por: Ruigrok, Eline A. M., et al.
Publicado: (2022)